Blog

Dr. Mutti on Current Role of Immunotherapy for Mesothelioma – OncLive

Dr. Mutti on Current Role of Immunotherapy for Mesothelioma
OncLive
The response rate of immunotherapy is not particularly effective, but Mutti says it is particularly important to look at what the survival rate will be in the future for a patient treated with immunotherapy. Until these results are available

2017-02-10 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.